Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -582.79x is 17% above its 3-year average of -703.12x, near the high end of its 3-year range (-3777.88x–-0.44x).
As of the fiscal period ended Tuesday, June 30, 2026. 58.45% above its 12-month average of -1402.59x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -582.79x.
INTEREST COVERAGE RATIO
-582.79x
INTEREST COVERAGE RATIO AVG TTM
-1402.59x
INTEREST COVERAGE RATIO AVG 3Y
-703.12x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+58.45%
CURRENT VS 3Y AVG
+17.11%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-9041.74%
vs the sector median at left
Telomir Pharmaceuticals, Inc. Common Stock
Market Cap
$81.84M
Interest Coverage Ratio
-582.79x
TTM Avg
-1402.59x
3Y Avg
-703.12x
5Y Avg
N/A
Market Cap
$81.88M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$83.21M
Interest Coverage Ratio
-369.11x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$80.90M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$83.24M
Interest Coverage Ratio
N/A
TTM Avg
26.56x
3Y Avg
26.56x
5Y Avg
26.56x
Market Cap
$83.61M
Interest Coverage Ratio
9.46x
TTM Avg
9.46x
3Y Avg
9.46x
5Y Avg
9.46x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | $81.84M | -582.79x | -1402.59x | -703.12x | N/A |
| ProMIS Neurosciences, Inc. (PMN)vs › | $81.88M | N/A | N/A | N/A | N/A |
| Nutriband Inc. (NTRB)vs › | $83.21M | -369.11x | N/A | N/A | N/A |
| Humacyte, Inc. (HUMA)vs › | $82.19M | -9.55x | N/A | N/A | N/A |
| MediciNova, Inc. (MNOV)vs › | $82.20M | N/A | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $80.90M | N/A | N/A | N/A | N/A |
| LENSAR Inc (LNSR)vs › | $82.78M | N/A | N/A | N/A | N/A |
| Cardiff Oncology, Inc. (CRDF)vs › | $83.24M | N/A | 26.56x | 26.56x | 26.56x |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $83.61M | 9.46x | 9.46x | 9.46x | 9.46x |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.14M | -3676.85x | N/A | N/A | N/A |
Interest Coverage
-582.8x
Debt/Equity
0.00
Current Ratio
16.14
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -582.79x |
| 2026-03-31 | -829.75x |
| 2025-09-30 | -419.95x |
| 2025-06-30 | -3777.88x |
| 2024-03-31 | -0.44x |
| 2023-12-31 | -1.42x |
| 2023-09-30 | -1.26x |
| 2023-06-30 | -11.50x |
